“…A number of effector strategies have been developed in mosquitoes, including RNA interference (28,85,86,145,156,195,237), single-chain antibodies (29,69,238), peptides (116,163,239), toxic proteins (19), and upregulation of immune factors (77). Recently, CRISPR has expanded this toolbox to include antiviral effector development.…”